Omnicell
OMCL
245 hedge funds and large institutions have $3B invested in Omnicell in 2018 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 69 increasing their positions, 116 reducing their positions, and 24 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 5 → 10 (+5)
46% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 24
4% more funds holding
Funds holding: 236 → 245 (+9)
2.78% less ownership
Funds ownership: 108.85% → 106.07% (-2.8%)
11% less capital inflows, than outflows
Capital inflows: $273M | Capital outflows: $308M
41% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 116
59% less call options, than puts
Call options by funds: $3.28M | Put options by funds: $8.02M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$52.3M |
| 2 |
CRCP
Copper Rock Capital Partners
Boston,
Massachusetts
|
+$28.6M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$24.3M |
| 4 |
BlackRock
New York
|
+$20.6M |
| 5 |
Credit Suisse
Zurich,
Switzerland
|
+$17.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$47.5M |
| 2 |
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
-$39.1M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$30.1M |
| 4 |
Champlain Investment Partners
Burlington,
Vermont
|
-$22.5M |
| 5 |
Mesirow Financial Investment Management - Fixed Income
Chicago,
Illinois
|
-$16.9M |
OMCL Hedge Fund Activity: Q3 2018 in Review
245 of the 4,392 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q3 2018, worth a combined $3B — up 35% from $2.22B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new OMCL positions and 24 closed out — a net gain of 11 holders — while 69 added to existing stakes and 116 trimmed.
The largest buyer was Vanguard Group, adding an estimated $52.3M. The largest seller was Glenmede Trust, cutting an estimated $47.5M.
- 245 institutional investors held Omnicell (OMCL) as of Q3 2018, up from 236 in Q2 2018.
- Funds reported $3B of Omnicell stock for Q3 2018, up 35% quarter-over-quarter.
- 35 funds opened new Omnicell positions in Q3 2018 and 24 closed out, a net change of +11 holders.
- The largest Omnicell buyer in Q3 2018 was Vanguard Group, an estimated $52.3M added.
- The largest Omnicell seller in Q3 2018 was Glenmede Trust, an estimated $47.5M sold.
Based on aggregated 13F filings for Q3 2018.